Page 19 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

List of Contributors xvii

Matthew David Morgan, M.B., Ch.B., Ph.D.
Renal Immunobiology
Centre for Translational Inflammation Research
School of Immunity and Infection
College of Medical and Dental Sciences
University of Birmingham
Birmingham, United Kingdom
Classification and Pathogenicity of ANCA-Associated Vasculitis (Chapter 10)
Systemic Vasculitis of the Gastrointestinal Tract (Chapter 15)

Luc Mouthon, M.D., Ph.D.
Department of Internal Medicine
National Reference Center for Rare Autoimmune and Systemic Diseases
INSERM U1060
Hôpital Cochin, Assistance Publique–Hôpitaux de Paris
University of Paris 5-René-Descartes, Paris Cedex 14, France
Immunosuppressant Medications Employed in Primary Systemic Vasculitides (Chapter 31)
Tribute to Loic Guillevin: His Career and Achievements (Chapter 32)

Seza Ozen, M.D.
Department of Pediatric Rheumatology
Hacettepe University School of Medicine
Sihhiye/Ankara 06410, Turkey
Classification of Pediatric Vasculitides (Chapter 7)

Stephen A. Paget, M.D.
Division of Rheumatology
Hospital for Special Surgery
New York, New York, USA
Clinical Approach to Patients with Vasculitis (Chapter 9)

Christian Pagnoux, M.D., M.P.H.
Mount Sinai Hospital
Division of Rheumatology – Vasculitis Clinic
Toronto, Ontario, Canada
Systemic Vasculitis and the Lung (Chapter 13)

William F. Pendergraft III, M.D., Ph.D.
University of North Carolina Kidney Center
Department of Medicine, Division of Nephrology and Hypertension
University of North Carolina-Chapel Hill
Chapel Hill, North Carolina, USA
Systemic Vasculitis and the Kidney: ANCA Vasculitis and Glomerulonephritis (Chapter 13)

Complimentary Contributor Copy